✨ Free AI Report
OptiNose, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview OptiNose, Inc.
Research Preview

OptiNose, Inc.: Business Overview, Financials & Competitive Analysis

OptiNose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists. The company leve...

Analyst-debate audio for OptiNose, Inc.

AskCyborg analysts argue the bull and bear cases for OptiNose, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
OptiNose, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Differentiated nasal delivery platform acquired for strategic consolidation in specialty...

Read the full analyst-debate transcript →
Industry Specialty Pharmaceuticals - ENT & Allergy
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 29, 2026
AI-Verified Research
30+ Page Report

Get the Latest OptiNose, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

OptiNose, Inc. Overview

Pro stress-test →

OptiNose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists. The company leverages proprietary nasal drug delivery technology to address underserved markets in ENT and allergy treatment.

Strategic Profile

Pro stress-test →

OptiNose is focused on value creation through its unique and novel drug delivery concept known as Bi-Directional Exhalation Delivery Systems. The technology allows drugs to be more efficiently delivered to the nasal cavity, with most of the dose deposited beyond the nasal valve in the upper posterior two-thirds of the nasal cavity, unlike traditional devices.

Competitive Landscape

Pro stress-test →

OptiNose competes in the specialty ENT pharmaceutical market against regional and global players. Primary competitors in nasal delivery include companies focused on rhinosinusitis, allergy treatments, and migraine therapies using alternative delivery mechanisms.

Industry Context

OptiNose, Inc. operates in Specialty Pharmaceuticals - ENT & Allergy.

Key facts

Founded: 2010 · Headquarters: Yardley, US · Employees: 141

What the analysts stress-tested

The top findings that survived the multi-agent debate for OptiNose, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when OptiNose, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Lyra TherapeuticsENT drug delivery and sustained-release therapies→LTS Lohmann Therapie-SystemePharmaceutical delivery systems and therapies→Currax PharmaceuticalsPartner for ONZETRA Xsail migraine treatment→

Compare OptiNose, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

OptiNose, Inc. operates in Specialty Pharmaceuticals - ENT & Allergy. See how the rest of the sector scores on the Cyborg framework.

Browse Specialty Pharmaceuticals - ENT & Allergy research →
NEW · MCP server

Ask your AI assistant about OptiNose, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare OptiNose, Inc. and its top competitor on Cyborg Score”
“What did OptiNose, Inc. do this quarter?”
“Is OptiNose, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does OptiNose, Inc. do?+
OptiNose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists. The company leve...
What is OptiNose, Inc.'s Cyborg Score?+
OptiNose, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are OptiNose, Inc.'s main competitors?+
Named competitors include Lyra Therapeutics, LTS Lohmann Therapie-Systeme, Currax Pharmaceuticals. The full competitive landscape is in the AskCyborg report.
How can I get the full OptiNose, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the OptiNose, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track OptiNose, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9GELEX Group Joint Stock Company9TTM Technologies, Inc.9Insulet Corporation9Marathon Petroleum Corporation9Seagate Technology Holdings plc9Howmet Aerospace Inc.9Investor AB9Micron Technology, Inc.9Taiwan Semiconductor Manufacturing Company Limited9NVIDIA Corporation8NIO Inc.8Seanergy Maritime Holdings Corp.8Grupo Aeroméxico, S.A.B. de C.V.8Gulf Medical Projects Company8Interloop Limited8Kyverna Therapeutics, Inc.8Tatton Asset Management Plc8Invictus Investment Company PLC